AU2003215235A1 - Cks1 INHIBITORS - Google Patents

Cks1 INHIBITORS

Info

Publication number
AU2003215235A1
AU2003215235A1 AU2003215235A AU2003215235A AU2003215235A1 AU 2003215235 A1 AU2003215235 A1 AU 2003215235A1 AU 2003215235 A AU2003215235 A AU 2003215235A AU 2003215235 A AU2003215235 A AU 2003215235A AU 2003215235 A1 AU2003215235 A1 AU 2003215235A1
Authority
AU
Australia
Prior art keywords
cks1
inhibitors
cks1 inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003215235A
Other languages
English (en)
Other versions
AU2003215235A8 (en
Inventor
Anne B. Jefferson
Christoph Reinhard
Blanche-Marie F. Shamoon
Annette O. Walter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Vaccines and Diagnostics Inc
Original Assignee
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiron Corp filed Critical Chiron Corp
Publication of AU2003215235A1 publication Critical patent/AU2003215235A1/en
Publication of AU2003215235A8 publication Critical patent/AU2003215235A8/xx
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Plant Pathology (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2003215235A 2002-02-12 2003-02-12 Cks1 INHIBITORS Abandoned AU2003215235A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US35690602P 2002-02-12 2002-02-12
US60/356,906 2002-02-12
PCT/US2003/004550 WO2003068939A2 (fr) 2002-02-12 2003-02-12 Inhibiteurs de cks1

Publications (2)

Publication Number Publication Date
AU2003215235A1 true AU2003215235A1 (en) 2003-09-04
AU2003215235A8 AU2003215235A8 (en) 2003-09-04

Family

ID=27734702

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003215235A Abandoned AU2003215235A1 (en) 2002-02-12 2003-02-12 Cks1 INHIBITORS

Country Status (5)

Country Link
EP (1) EP1480995A4 (fr)
JP (1) JP2005523280A (fr)
AU (1) AU2003215235A1 (fr)
CA (1) CA2474844A1 (fr)
WO (1) WO2003068939A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2954896A1 (fr) * 2014-06-13 2015-12-16 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Inhibiteurs à petite molécule de la ligase de Skp2 E3 dans la dépression et d'autres maladies

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5801015A (en) * 1995-06-05 1998-09-01 Mitotix, Inc. Nucleic acid encoding a Candida cell cycle regulatory protein, TYP1 polypeptide
US5981702A (en) * 1995-09-21 1999-11-09 Cold Spring Harbor Laboratory Cyclin/CDK associated proteins, and uses related thereto
WO1998041642A1 (fr) * 1997-03-14 1998-09-24 Cropdesign N.V. Procede et moyens de modulation des proteines du cycle cellulaire des plantes et utilisation de ces moyens pour controler la croissance cellulaire des plantes
US6573094B1 (en) * 1997-10-16 2003-06-03 Baylor College Of Medicine F-box genes and proteins
NZ527047A (en) * 2001-01-05 2006-09-29 Univ New York Methods to identify compounds useful for the treatment of proliferative and differentiative disorders
WO2002068444A1 (fr) * 2001-02-21 2002-09-06 Chiron Corporation Utilisation de la ttk à des fins de diagnostic et comme cible thérapeutique du cancer

Also Published As

Publication number Publication date
JP2005523280A (ja) 2005-08-04
CA2474844A1 (fr) 2003-08-21
WO2003068939A2 (fr) 2003-08-21
EP1480995A2 (fr) 2004-12-01
WO2003068939A3 (fr) 2003-12-31
EP1480995A4 (fr) 2006-09-13
AU2003215235A8 (en) 2003-09-04

Similar Documents

Publication Publication Date Title
AU2003202263A1 (en) Roh-kinase inhibitors
AU2003255376A1 (en) Piperidine-derivatives as pde4 inhibitors
AU2003239909A1 (en) Enhanced-service provision
AU2002335152A1 (en) Robot-phone
AU2003300832A1 (en) NF-KappaB INHIBITORS
AU2003249683A1 (en) Nf-:b inhibitors
AU2003255952A1 (en) Oxytocin inhibitors
AU2003238042A1 (en) Cyclooxygenase-2 inhibitors
AU2003252593A1 (en) Sulfotransferase inhibitors
AU2003224941A1 (en) NF-KappaB INHIBITORS
AU2002367810A1 (en) Bis-transition-metal-chelate-probes
AU2003232362A1 (en) 4-pyrazol-phenylalanine derivatives as ace-nep inhibitors
AU2002368348A1 (en) Electrosomatogram
AU2003215235A1 (en) Cks1 INHIBITORS
AU2002348964A1 (en) Snowbike
AU2002341221A1 (en) Honey-brandy
AU2002344387A1 (en) Multifunction-pillow
AU2002100510A4 (en) Bottlenecker
AU2002100031A4 (en) earliPay
AU2002100739A4 (en) Neuramax
AU2002100655A4 (en) Armamulch
AU2002100602A4 (en) Bonsystem
AU2002100957A4 (en) Sluggit
AU2002100747A4 (en) Powersell
AU2002100508A4 (en) Photocard

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase